You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

ACOG MEMBER SUBSCRIPTION ACCESS

If you are an ACOG Fellow and have not logged in or registered to Obstetrics & Gynecology, please follow these step-by-step instructions to access journal content with your member subscription.

Early Hysteroscopic Removal of Intratubal Microinserts With Urologic Stone Retrieval Forceps

Goldthwaite, Lisa M. MD; Edwards, Lindsay MD, PhD; Tocce, Kristina MD, MPH

Obstetrics & Gynecology:
doi: 10.1097/AOG.0000000000000338
Case Report
Abstract

BACKGROUND: Nickel hypersensitivity reactions can be an indication for the removal of intratubal microinserts used for hysteroscopic sterilization. Although early removal can be attempted hysteroscopically, hysteroscopic grasping forceps may be inadequate to grasp deeply positioned inserts.

CASE: Three days after hysteroscopic sterilization, the patient presented with a rash consistent with a nickel hypersensitivity reaction. Ten days after placement, we successfully performed hysteroscopic removal of an intratubal microinsert with tri-prong urologic stone retrieval forceps after standard hysteroscopic grasping forceps was unable to reach the deeply positioned device. Within 36 hours of bilateral microinsert removal, all symptoms resolved.

CONCLUSION: In difficult cases, 1-mm tri-prong urologic stone retrieval forceps can be useful for early hysteroscopic removal of intratubal microinserts.

In Brief

In difficult cases, 1-mm tri-prong urologic stone retrieval forceps can be useful for early hysteroscopic removal of intratubal microinserts.

Author Information

Division of Family Planning, Department of Obstetrics and Gynecology, University of Colorado Denver School of Medicine, Aurora, Colorado.

Corresponding author: Lisa M. Goldthwaite, MD, University of Colorado Denver School of Medicine, Department of Obstetrics and Gynecology, 12631 E. 17th Avenue, Box B-198-2, Aurora, CO 80045; e-mail: lisa.goldthwaite@ucdenver.edu.

Financial Disclosures Kristina Tocce, MD, MPH, has served as a physician consultant for Conceptus and participated in the Bayer HeathCare Essure National Advisory Board Meeting in January 2014. The other authors did not report any potential conflicts of interest.

© 2014 by The American College of Obstetricians and Gynecologists.